View of Updated meta-analysis of randomized trials: pathological complete response as a prognostic marker for survival in breast cancer treated with neoadjuvant chemotherapy

Return to Article Details Updated meta-analysis of randomized trials: pathological complete response as a prognostic marker for survival in breast cancer treated with neoadjuvant chemotherapy Download Download PDF